Actively Recruiting
MYLUNG Consortium Part 3: Observational Study
Led by US Oncology Research · Updated on 2024-07-18
7500
Participants Needed
17
Research Sites
408 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This longitudinal study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and largely unselected patient population with early stage and advanced stage, treatment-naive non-small cell lung cancer, whether squamous or non-squamous.
CONDITIONS
Official Title
MYLUNG Consortium Part 3: Observational Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult subjects (18 years and older) with newly diagnosed early stage, locally advanced or metastatic non-small cell lung cancer
- Must be eligible for systemic therapy based on the treating provider's assessment, including those who declined recommended treatment
- Subjects who developed locally advanced or metastatic disease at least 12 months after completing adjuvant or neoadjuvant therapy
- Subjects must be enrolled within 30 days of starting systemic therapy
- Signed informed consent
You will not qualify if you...
- Stage IA lung cancer at the time of enrollment
- Subjects with small cell lung cancer
- Subjects with unknown primary tumor origin
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 17 locations
1
Southern Cancer Center, PC
Daphne, Alabama, United States, 36526
Actively Recruiting
2
Arizona Oncology Associates, PC - NAHOA
Prescott Valley, Arizona, United States, 86314
Not Yet Recruiting
3
Rocky Mountain Cancer Center
Denver, Colorado, United States, 80218
Active, Not Recruiting
4
Cancer Care Centers of Brevard, Inc.
Palm Bay, Florida, United States, 32901
Actively Recruiting
5
Woodlands Medical Specialists, PA
Pensacola, Florida, United States, 32503
Active, Not Recruiting
6
Affiliated Oncologists, LLC
Chicago Ridge, Illinois, United States, 60415
Actively Recruiting
7
Illinois Cancer Specialists
Niles, Illinois, United States, 60714
Active, Not Recruiting
8
Maryland Oncology Hematology, P.A.
Silver Spring, Maryland, United States, 20904
Active, Not Recruiting
9
Minnesota Oncology Hematology, P.A.
Minneapolis, Minnesota, United States, 55404
Active, Not Recruiting
10
New York Oncology Hematology, P.C.
Albany, New York, United States, 12208
Actively Recruiting
11
Oncology Hematology Care Clinical Trials, LLC
Cincinnati, Ohio, United States, 45242
Actively Recruiting
12
Willamette Valley Cancer Institute and Research Center
Eugene, Oregon, United States, 97401
Actively Recruiting
13
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care
Blacksburg, Virginia, United States, 24060
Actively Recruiting
14
Virginia Cancer Specialists, PC
Fairfax, Virginia, United States, 22031
Active, Not Recruiting
15
Virginia Oncology Associates
Newport News, Virginia, United States, 23606
Actively Recruiting
16
Shenandoah Oncology, P.C.
Winchester, Virginia, United States, 22601
Active, Not Recruiting
17
Northwest Cancer Specialists, P.C.
Vancouver, Washington, United States, 98684
Actively Recruiting
Research Team
A
Andrea Glidden, BSN, OCN
CONTACT
T
Taqi Mohammad
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here